Related Experiment Videos

[Cardiac sarcoidosis: improved prognosis through new diagnostic tests and treatment]

J P Smedema1, L van Erven, J H M Schreur

  • 1Afd. Cardiologie, Academisch Ziekenhuis Maastricht, Maastricht. jansmedema@hotmail.com

Nederlands Tijdschrift Voor Geneeskunde
|June 9, 2005
PubMed

Insights

Cardiac sarcoidosis, a serious heart condition, can be effectively managed. Early detection using advanced imaging and treatments like pacemakers improve patient outcomes.

Area of Science:

  • Cardiology
  • Immunology
  • Medical Imaging

Background:

  • Cardiac sarcoidosis affects 20-30% of sarcoidosis patients, leading to significant morbidity and mortality.
  • Early diagnosis and intervention are crucial for managing this multi-system granulomatous disorder.

Observation:

  • Three cases of cardiac sarcoidosis are presented: two men with ventricular tachycardia and one woman with progressive cardiac symptoms.
  • Diagnostic methods included right-ventricle biopsy, gallium scintigraphy, and assessment of cardiac symptoms in a patient with pulmonary sarcoidosis.

Findings:

  • Treatment strategies involved immunosuppression, heart-failure medication, implantable defibrillators, radio-frequency catheter ablation, and biventricular pacemakers.
  • Outcomes varied, with one patient recovering fully, another experiencing severe heart failure despite aggressive treatment, and a third recovering with a pacemaker.

Implications:

  • Advanced imaging like gadolinium MRI and positron emission tomography (PET) aid in earlier detection and treatment evaluation.
  • Therapies such as resynchronisation therapy and implantable defibrillators have improved the prognosis for patients with cardiac sarcoidosis.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...